Response to Hanif and Sholihah
J Natl Cancer Inst
.
2025 Oct 1;117(10):2144-2145.
doi: 10.1093/jnci/djaf226.
Authors
Doratha A Byrd
1
,
Maria Gomez
1
,
Stephanie Hogue
2
,
Yunhu Wan
3
,
Ana Maria Ortega-Villa
4
,
Andrew Warner
5
,
Casey Dagnall
3
5
,
Kristine Jones
3
5
,
Belynda Hicks
3
5
,
Paul Albert
3
,
Gwen Murphy
6
,
Rashmi Sinha
3
,
Emily Vogtmann
3
Affiliations
1
Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, United States.
2
Non-Therapeutic Research Office, Moffitt Cancer Center, Tampa, FL, United States.
3
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, United States.
4
Division of Clinical Research, National Institute of Allergy and Infectious Diseases, Rockville, MD, United States.
5
Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, Frederick, MD, United States.
6
Cancer Screening and Prevention Research Group, Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
PMID:
40828889
PMCID:
PMC12505123
DOI:
10.1093/jnci/djaf226
No abstract available
Grants and funding
CA/NCI NIH HHS/United States
75N91019D00024/NH/NIH HHS/United States
HH/HHS/United States